We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
USA - November 15 2012
On 14 November 2012, the U.S. Department of Justice and U.S. Securities and Exchange Commission issued their long awaited “guidance” on the Foreign Corrupt Practices Act (FCPA), FCPA: A Resource Guide to the U.S. Foreign Corrupt Practices Act.
Brazil, China, France, Germany, Middle East, Russia, Spain, United Kingdom, USA - January 31 2012
Over the past several years, legal counsel have continued to advise their clients that anti-bribery and corruption efforts by governments worldwide were on the increase.
USA - May 10 2011
The criminal prosecution of former GlaxoSmithKline (GSK) in-house counsel, Lauren Stevens, for purportedly obstructing a U.S. Food and Drug Administration (FDA) investigation and making allegedly false statements is over for Stevens.
USA - March 25 2011
The indictment last November of former GlaxoSmithKline (GSK) in-house counsel, Lauren Stevens, for purportedly obstructing a U.S. Food and Drug Administration (FDA) investigation into whether GSK marketed Wellbutrin, an anti-depressant drug, off-label, falsifying and concealing documents, and making false statements sent shockwaves through the legal community.
USA - January 20 2011
2010 proved to be another record year for Foreign Corrupt Practices Act (FCPA) enforcement actions by the Department of Justice (DOJ) and the Securities and Exchange Commission (SEC), the two agencies tasked with enforcing the FCPA.
